1. Home
  2. NMAI vs EMBC Comparison

NMAI vs EMBC Comparison

Compare NMAI & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Multi-Asset Income Fund of Beneficial Interest

NMAI

Nuveen Multi-Asset Income Fund of Beneficial Interest

HOLD

Current Price

$12.79

Market Cap

461.6M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.84

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMAI
EMBC
Founded
2021
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
461.6M
521.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NMAI
EMBC
Price
$12.79
$8.84
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
103.2K
750.8K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
13.14%
6.83%
EPS Growth
N/A
20.90
EPS
0.64
0.74
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$19.83
$11.88
Revenue Growth
N/A
N/A
52 Week Low
$10.21
$8.77
52 Week High
$13.96
$15.55

Technical Indicators

Market Signals
Indicator
NMAI
EMBC
Relative Strength Index (RSI) 30.19 33.18
Support Level $12.72 N/A
Resistance Level $12.74 $10.88
Average True Range (ATR) 0.21 0.31
MACD -0.10 -0.06
Stochastic Oscillator 4.27 5.68

Price Performance

Historical Comparison
NMAI
EMBC

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: